Leading Value Strategy Consultancy Deepens ICON's Pricing and Market Access Capabilities DUBLIN, Feb 28, 2012 (BUSINESS WIRE) -- ICON plc, ICLR -0.09% (isin:IE0005711209), a global provider of ...

Dublin-based Icon, which reported $2.8 billion in sales last year, helps pharmaceutical companies run studies testing experimental drugs and vaccines in people, including deploying nurses to ...

Mary brings to ICON over 15 years of global pharmaceutical and clinical development expertise with a strong track record in Asia. Mary joins ICON from Becton Dickinson, a leading medical ...

Irish contract research organization ICON (Nasdaq: ICON) has retained its position as the most active CRO worldwide in the ...

Biotech Stocks Sure Look Like A Bubble "The ... Our Verdict Read next BI Tech Memo An icon in the shape of an angle pointing down.

Special Counsel Says ICON CEO Steve Cutler says trial activity has been “impacted by cautious spending from biopharma customers in both the biotech and large pharma businesses.” The company ...

Bishop and other Juno employees once worked at early cell therapy company Dendreon, co-founded by early Seattle biotech icon Christopher Henney. Henney left a position at Fred Hutch in 1980 to co ...

"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from ...